These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3663446)

  • 1. The accuracy of a pharmacokinetic theophylline predictor using once daily dosing.
    Chrystyn H; Mulley BA; Peake MD
    Br J Clin Pharmacol; 1987 Sep; 24(3):301-7. PubMed ID: 3663446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian derived predictions for twice daily theophylline under outpatient conditions and an assessment of optimal sampling times.
    Chrystyn H; Ellis JW; Mulley BA; Peake MD
    Br J Clin Pharmacol; 1989 Feb; 27(2):215-21. PubMed ID: 2713215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a novel Bayesian method for individualizing theophylline dosage.
    Stein U; Oellerich M; Sybrecht GW; Schneider B
    J Clin Chem Clin Biochem; 1988 Jun; 26(6):405-14. PubMed ID: 3411295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individualization of theophylline dosage: a Bayesian method evaluated in patients with once-daily dosing.
    Martz W; Oellerich M; Schnabel D; Sybrecht GW
    Ther Drug Monit; 1991 Sep; 13(5):420-4. PubMed ID: 1957334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The accuracy and stability of Bayesian theophylline predictions.
    Chrystyn H; Ellis JW; Mulley BA; Peake MD
    Ther Drug Monit; 1988; 10(3):299-305. PubMed ID: 3176107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The design of oral sustained-release theophylline dosing after conversion from intravenous to oral therapy.
    Yamazaki M; Fukutomi O; Kondo N; Kato Z; Nakashima Y; Shinoda S; Agata H; Kondo T; Imaeda N; Orii T
    Int J Clin Pharmacol Ther; 1994 Nov; 32(11):625-31. PubMed ID: 7874380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abbott PKS system: a new version for applied pharmacokinetics including Bayesian estimation.
    Lacarelle B; Pisano P; Gauthier T; Villard PH; Guder F; Catalin J; Durand A
    Int J Biomed Comput; 1994 Jun; 36(1-2):127-30. PubMed ID: 7927851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of three theophylline dosing methods in pediatric patients.
    Godley PJ; Karboski JA; Godley SE; Edwards GA; Moore ES; Sagraves R
    DICP; 1991 Feb; 25(2):179-85. PubMed ID: 2058190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the accuracy of a least squares regression, a Bayesian, Chiou's and the steady-state clearance method of individualising theophylline dosage.
    Hurley SF; McNeil JJ
    Clin Pharmacokinet; 1988 May; 14(5):311-20. PubMed ID: 3396259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Theophylline levels after single daily and divided dosing of a once-a-day theophylline preparation in asthmatic children.
    Boner AL; Sette L; Vallone G; Plebani M; Messori A
    Ann Allergy; 1989 Feb; 62(2):149-53. PubMed ID: 2919803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pharmacokinetic dosing method for oral theophylline in pediatric patients.
    Brocks DR; Lee KC; Tam YK; Weppler CP; Bradley JM
    Ther Drug Monit; 1988; 10(1):58-63. PubMed ID: 3376182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theophylline therapeutic drug monitoring in the case of a new sustained-release pellet formulation for once-daily evening administration.
    Steinijans VW; Trautmann H; Sauter R; Staudinger H
    Arzneimittelforschung; 1988 Aug; 38(8A):1251-3. PubMed ID: 3190814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of once-daily theophylline dose following the morning versus evening administration.
    Trnavská Z; Vondra V; Elis J
    Arzneimittelforschung; 1989 Sep; 39(9):1149-51. PubMed ID: 2590267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Once-daily dosing of a new ultrasustained-release theophylline preparation.
    Van den Brande P; Nys J; Tjandramaga TB; Verhelst F; Demedts M
    Respiration; 1987; 52(2):144-53. PubMed ID: 3671893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of intravenous theophylline dosage based on a single, nonsteady-state concentration: a clinical study of childhood status asthmaticus.
    Kurland G; Anderson DA; Mitsuoka JC; Marquardt ED
    Pediatrics; 1988 Dec; 82(6):880-3. PubMed ID: 3186378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic comparison of a once-daily and twice-daily theophylline delivery system.
    González MA; Kisicki J; Straughn AB
    Clin Ther; 1994; 16(4):686-92. PubMed ID: 7982257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computer prediction of serum theophylline concentrations in ambulatory patients.
    Deci PA; Lopez LM; Robinson JD; Grauer K
    Ther Drug Monit; 1985; 7(4):421-5. PubMed ID: 3841237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with a computer-based technique for estimating pharmacokinetic constants from limited data.
    Bachmann K; Pongsin V; Forney R; Gronau G
    Ther Drug Monit; 1985; 7(3):258-64. PubMed ID: 4049460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictability and intraindividual variability of serum theophylline concentrations in patients with obstructive lung disease: 12-h versus 24-h dosing.
    Schmidlin O; Vozeh S; Keller B; Perruchoud A; Follath F
    Eur J Clin Pharmacol; 1990; 39(3):253-6. PubMed ID: 2257861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relative predictive performance of two theophylline pharmacokinetic dosing programs.
    Hoon TJ; Wood CA; Whidden MA; Greene WL; Bottorff MB
    Pharmacotherapy; 1988; 8(2):82-8. PubMed ID: 3399424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.